Seeking Alpha

Merck (MRK): Q2 EPS of $0.86 beats by $0.03. Revenue of $6.05B (-1%) in-line. No guidance as it...

Merck (MRK): Q2 EPS of $0.86 beats by $0.03. Revenue of $6.05B (-1%) in-line. No guidance as it is still assessing the impact of today's Vytorin test results. Shares -4.3%. [PR]
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)